Maze Therapeutics announced completion of enrollment in its Phase 2 HORIZON trial for MZE829, a drug targeting APOL1-mediated kidney disease, exceeding patient targets. Interim data showed promising reductions in proteinuria, with full results expected in early 2027 to guide a pivotal trial planned for mid-2027. The company is also advancing MZE782 in Phase 2 trials for phenylketonuria and chronic kidney disease, with topline data expected in 2027 and a new trial planned for H1 2027. Maze reported a strong cash position of $477 million supporting operations through 2029, despite a net loss of $48 million in Q3 2026 due to increased R&D and administrative expenses.
Maze Therapeutics' Q3 2026 results provide context for health sector investors. For readers following health stocks, here is Pluang's market snapshot as of Nov 10, 2026 04:11 WIB: Out of 150 health-sector US stocks, 125 rose and 23 fell today. Notable movers include IBRX at USD 7.11 with a -17.66% change and 96% buy orders, HIMS at USD 21.66 down -16.69% with 100% buy orders, and ARWR at USD 49.30 down -15.23%.
AmpliTech Group, a company specializing in RF and microwave components for telecom and defense, will announce its third quarter 2026 financial results on November 12, 2026, after market close. The company will host a conference call at 5:00 PM ET the...
Toll Brothers has announced the grand opening of new luxury single-story model homes at Hidden Vista, a gated community in Palm Desert, California, on November 14. These homes offer up to 2,700 sq ft with 3-4 bedrooms, modern open floor plans, and pr...
FocusReactive, a web development agency specializing in Next.js and headless CMS, achieved top rankings across six major industry review platforms in 2026, including Clutch, DesignRush, and The Manifest. The agency was recognized globally for experti...
Indonesia's e-commerce market is projected to grow from $120.2 billion in 2027 to $239.4 billion by 2032, with a CAGR of 14.78%. Growth is fueled by rising mobile commerce adoption, live-stream shopping, digital payment solutions like PayLater, and e...
Security National Financial Corporation reported a 38.6% drop in after-tax earnings for Q3 2026, falling to $6.17 million due to challenging mortgage market conditions and increased interest rates. The mortgage segment faced a $2.65 million loss driv...
